Business Context and Reporting Period
This Form 6-K was filed by Alterity Therapeutics Limited, a development stage enterprise headquartered in Melbourne, Australia, for the month of July 2021. The report was signed on July 6, 2021, by Geoffrey P. Kempler, Chairman.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. As a development stage enterprise, the document focuses on regulatory filings rather than financial performance data.
Material Changes
The primary material event disclosed is the submission of an "Application for quotation of securities" (Exhibit 99.1) for the ticker symbol ATH. The filing does not detail comparative financial changes versus prior periods.
Guidance, Outlook, and Risks
The document does not contain management commentary, financial guidance, or specific risk factors. It serves primarily to incorporate the securities quotation application by reference into existing Registration Statements on Form S-8 and Form F-3.
Investor Verification Checklist
- Verify the status and approval of the securities quotation application for ticker symbol ATH.
- Review the referenced Registration Statements (Form S-8 and Form F-3) for detailed capital structure and offering terms.
- Confirm the company's current cash position and runway, as no financial data is included in this specific filing.